CeriBell, Inc.

CBLL

$24.57

-0.97%

N/A-$0.24

Healthcare

Medical - Devices

NASDAQ

Active Trading

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly ...

Financial Highlights of CBLL

Profitability trend

Latest / TTM · 5 periods

Gross Margin

88.9%

Net Margin

-64.7%

P/E Ratio

-13.96x

n/a

Debt / Equity

0.17

n/a

Current Ratio

9.18

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 5 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

88.9%

Net Margin

-64.7%

P/E Ratio

-13.96x

Debt / Equity

0.17

Profitability

Profitability table

Metric	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	82.9%	84.4%	86.7%	87.9%	—
Operating MarginOperating income as a percentage of revenue.	-139.0%	-66.4%	-60.7%	-65.6%	—
Net MarginNet income as a percentage of revenue.	-143.4%	-65.1%	-61.8%	-60.0%	—
EBITDA MarginEBITDA divided by revenue.	-135.3%	-58.6%	-57.0%	-56.3%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-143.4%	-65.1%	-61.8%	-60.0%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	8.09	2.41	16.73	9.73	—
Quick RatioLiquid assets divided by current liabilities.	7.68	2.13	16.19	9.35	—
Cash RatioCash and equivalents divided by current liabilities.	6.92	1.60	14.96	2.11	—
Debt / AssetsDebt as a share of total assets.	21.1%	24.1%	9.7%	11.4%	—
Debt / EquityDebt compared with shareholder equity.	-0.21	-0.13	0.11	0.14	—

Operating efficiency

Operating efficiency table

Metric	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	4.90x	5.69x	6.02x	5.92x	—
Inventory TurnoverHow often inventory is sold in a year.	1.09x	1.20x	1.25x	1.48x	—
Payables TurnoverHow often payables are paid in a year.	10.47x	9.65x	7.61x	3.80x	—
Asset TurnoverRevenue generated per dollar of assets.	0.30x	0.77x	0.29x	0.45x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.00x	0.90x	0.56x	0.48x	—

Valuation ratios

Valuation ratios table

Metric	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-15.72x	-19.84x	-22.90x	-15.02x	—
P/B RatioPrice paid for each dollar of book value.	-6.75x	-5.19x	4.85x	5.16x	—
P/S RatioPrice paid for each dollar of sales.	22.49x	12.89x	14.18x	9.00x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-17.93x	-19.35x	-25.50x	-19.28x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	—

Supply Chain of CBLL

RELATIONS

Upstream

Shenzhen Everwin Precision Technology Co., Ltd.SZSE:300115LKK (Beijing LKK Technology Co., Ltd. / LKK Supply Chain Management)Whipsaw Inc.Electronic Component Suppliers (PCB, Battery, LCD Display)Cloud Infrastructure Provider (AWS / Azure / GCP)UnconfirmedEverwin Vietnam (Everwin Precision Viet Nam Technology Co., Ltd.)

Downstream

Providence Health & ServicesFranciscan HealthTrinity Health Of New EnglandU.S. Department of Veterans Affairs (VA)Roxborough Memorial Hospital (Philadelphia)Mission Hospital (California)

Proxies

Shenzhen Everwin Precision Technology Co., Ltd.SZSE:300115Nihon Kohden CorporationTSE:6849LivaNova PLCNASDAQ:LIVN TPG Inc.NASDAQ:TPG

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer